The US cell-based immunotherapy market is expanding with increasing adoption of advanced cellular therapies for cancer treatment and growing investment in next-generation immunotherapy platforms. CAR-T cell therapies, engineered immune cells, and emerging allogeneic approaches are gaining attention as research advances and clinical applications broaden. Strong biotechnology infrastructure,...